Genomics
Genomics Market by Offering (Consumables, Instruments, Service), Technology (Gene Editing Technique, Microarray Technology, PCR Technology), Type, Applications, End Users - Global Forecast 2025-2030
SKU
MRR-434CCDA04CD1
Region
Global
Publication Date
February 2025
Delivery
Immediate
2024
USD 52.22 billion
2025
USD 57.15 billion
2030
USD 91.45 billion
CAGR
9.78%

The Genomics Market size was estimated at USD 52.22 billion in 2024 and expected to reach USD 57.15 billion in 2025, at a CAGR 9.78% to reach USD 91.45 billion by 2030.

Genomics Market
To learn more about this report, request a free PDF copy

The genomics market encompasses the study of genomes, which involves sequencing, analyzing, and interpreting genetic information. Its scope includes various applications in medicine, agriculture, forensic science, and biotechnology, driving advancements in personalized medicine, genetic therapies, and agricultural breeding. Genomics is necessary for understanding diseases at a molecular level, enabling the development of precise therapeutic interventions and diagnostic tools. This has significant applications in healthcare for disease prevention, management, and treatment personalization, with the pharmaceutical and biotech sectors being major end-users. Key growth factors influencing the genomics market include advancements in DNA sequencing technologies, a growing prevalence of genetic disorders, and increasing government and private funding in genetic research. Emerging opportunities lie in CRISPR and other gene-editing technologies, which promise breakthroughs in disease treatment and crop improvement. Market recommendations include investing in expanding bioinformatics capabilities to manage and interpret the vast amount of data generated. Another opportunity lies in developing affordable sequencing solutions to broaden accessibility in developing regions. However, the genomics market faces challenges such as ethical concerns about genetic testing, high costs of equipment and services, data privacy issues, and a shortage of skilled professionals. Overcoming these limitations involves addressing privacy through robust data security measures and ethical guidelines, as well as investing in workforce training. Areas ripe for innovation include integrating artificial intelligence and machine learning to enhance the precision of genomic analyses and exploring applications in epigenomics and metagenomics. The nature of the genomics market is highly dynamic and rapidly evolving, driven by technological advancements and increasing demand for innovative healthcare solutions. Companies that can navigate these challenges and leverage opportunities effectively may achieve significant growth by delivering new, impactful genomic solutions.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Genomics market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Genomics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Increasing prevalence of genetic disorders globally
    • Growing shift toward precision medicine and personalized therapeutics
    • Expanded application of genomics in agriculture and forensic science
  • Market Restraints
    • Concern associated with assessing genetic diversity used in testings
  • Market Opportunities
    • Integration of AI and advanced bioinformatics for automating and enhancing genomic data analysis
    • Increased funding and grants for research and development in genomics by governments and private organizations
  • Market Challenges
    • Lack of standardized methodologies reducing efficiency in the genomics field implementation

Market Segmentation Analysis

  • Offering: Higher significance of analyzers in genomics for diagnosing and understanding genetic diseases

    The field of genomics has enhanced the biological sciences by enabling in-depth genetic analysis that can be applied to various sectors, including healthcare, agriculture, and forensics. Consumables, which include kits & assays, and reagents, form a foundational component of genomics research and diagnostics. Kits and assays are pre-packaged sets of reagents and protocols used for conducting specific tests, such as DNA sequencing, amplification, and detection, offering ease of use, reliability, and standardization essential for both routine and sophisticated genomic applications. Reagents, on the other hand, are chemicals used in the processes of extraction, amplification, and analysis of genetic material, essential for the functionality of genomics assays. Instruments in genomics include analyzers and sequencers, critical tools that enable the interpretation of genetic material. Analyzers are devices used to evaluate biological samples and provide data regarding genetic composition, playing a vital role in diagnosing and understanding genetic diseases. Sequencers, meanwhile, are pivotal innovations in genomics as they determine the sequence of nucleotides in DNA, forming the backbone of genetic research and personalized medicine. The advancement in high-throughput sequencer technologies has drastically reduced the cost of sequencing, thereby expanding the market by making genome analysis more accessible to a range of users, including those in clinical diagnostics and consumer genomics. The services offered in the genomics market include sequencing services, bioinformatics analysis, and consulting. These services are pivotal for organizations that need to possess the capital or expertise to conduct complex genomic analyses in-house. The growing trend towards outsourcing genomics research due to its cost-effectiveness and the technical expertise required has significantly contributed to the expansion of this segment. Services also provide an entry point for smaller companies to leverage genomic insights without a substantial initial investment in equipment.

  • Technology: Extending applications of CRISPR/Cas9 owing to precision, efficiency, and versatility

    In the genomics sector, gene editing techniques are pivotal technologies driving advancements in understanding and manipulating genetic material. Among these techniques, CRISPR/Cas9, TALENs, and zinc finger nucleases (ZFNs) stand out for their distinct methodologies and applications. CRISPR/Cas9 or Clustered Regularly Interspaced Short Palindromic Repeats with CRISPR-associated protein 9, has enhanced gene editing with its precision, efficiency, and versatility. It leverages RNA molecules to guide Cas9 proteins to specific DNA sequences, enabling targeted modifications. CRISPR's simplicity and cost-effectiveness have broadened its adoption across research and therapeutic domains, propelling it to the forefront of genomic innovation. TALENs, or transcription activator-like effector nucleases, offer another robust gene editing approach by using engineered protein domains to recognize DNA sequences. Their design flexibility allows for high specificity, making TALENs suitable for applications requiring precision where CRISPR's off-target effects may be a concern. Despite being less popular than CRISPR due to its complexity and higher costs, TALENs remain a valuable tool for intricate genetic modifications. Zinc finger nucleases are among the earliest gene editing technologies, employing engineered zinc finger proteins coupled with a DNA-cleaving enzyme to target specific DNA sequences. Though surpassed by newer methods in terms of ease and efficiency, ZFNs are still employed in niche applications where their precision is beneficial. Microarray technology is a high-throughput method used to analyze the expression of numerous genes simultaneously. This method involves the use of microarrays, which are collections of microscopic spots of DNA, RNA, proteins, or tissues arranged on solid surfaces. Within this, cellular microarrays are a distinctive technology that focuses on the analysis of cellular components in a microarray format. They are particularly significant in exploring cellular functions and interactions at a large scale, allowing for the simultaneous observation of numerous cellular events. DNA microarrays, another critical segment, are used extensively for gene expression profiling, SNP detection, and comparative genomic hybridization. DNA microarrays facilitate the monitoring of thousands of genes in a single experiment, revolutionizing genotyping, personalized medicine, and cancer research. Protein microarrays, conversely, are used to study proteins, their interactions, functions, and abnormalities. This technology is pivotal in biomarker discovery, drug development, and disease diagnostics because it enables the analysis of protein-protein interactions, enzyme activities, and substrate specificities.

    Digital PCR (dPCR) is a refined version of PCR technology that allows for the absolute quantification of DNA molecules without standard curves. By partitioning the DNA sample into many individual reactions, digital PCR provides highly precise quantification, making it especially useful in detecting rare DNA targets and in applications such as copy number variation (CNV) analysis. End-point PCR is the traditional form of PCR where the amplified DNA products are analyzed after all the cycles are completed, typically via gel electrophoresis. This method provides qualitative data on the presence or absence of a DNA segment but lacks the ability to quantify the amount of DNA accurately. Real-time PCR, or quantitative PCR (qPCR), differs from end-point PCR in that it measures the amount of DNA during the amplification process in real-time. It uses fluorescent dyes or probes to provide quantitative data, allowing scientists to measure the exponential increase of DNA as it is being amplified. Next-generation sequencing (NGS) has revolutionized genomics by allowing for high throughput and rapid sequencing of large genomic fragments, thus significantly reducing time and costs compared to earlier methods. This technology enables researchers to conduct large-scale genomic projects such as whole-genome sequencing, transcriptome profiling, and various applications in clinical diagnostics and biotechnology. On the other hand, Sanger sequencing remains a gold standard for its accuracy and reliability, especially in smaller-scale projects and applications requiring precise DNA sequences, such as confirmatory testing and mutation verification. Although slower and more costly than NGS, it continues to be widely used for its time-tested accuracy and specificity. Third-generation sequencing, including technologies such as single-molecule real-time sequencing, aims to sequence DNA without amplification, offering longer read lengths and the ability to directly detect epigenetic modifications. This technology helps to further reduce sequencing costs and time while providing comprehensive genomic information.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Genomics Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Genomics Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Genomics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Genomics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Recent Developments

  • Novo Holdings acquired Benchmark Genetics for strategic growth and innovation

    Novo Holdings has agreed to acquire Benchmark Genetics for up to GBP 260 million, enhancing its focus on sustainable aquaculture technology. This acquisition includes an initial GBP 230 million and up to GBP 30 million in contingent considerations based on revenue targets. Benchmark Genetics, known for innovative salmonid genetics and serving 50+ countries, aims to improve aquaculture sustainability through enhanced growth and disease resistance. [Published On: November 25, 2024]

  • Solis Agrosciences enhances its genomic solutions with the acquisition of Ferris Genomics expertise and platform

    Solis Agrosciences' acquisition of Ferris Genomics enhances its genomics services by incorporating Ferris' sequencing and bioinformatics platform, including whole-genome sequencing and imputation capabilities. This involves integrating Ferris' key employees and operations, ensuring a smooth transition. Anticipated results include an immediate contribution to Solis' financial performance and expanded customer reach. [Published On: November 25, 2024]

  • Myriad Genetics partners with Ultima Genomics to enhance clinical tests using UG 100 sequencing

    Myriad Genetics and Ultima Genomics have collaborated to utilize the UG 100 Sequencing Platform to enhance Myriad's clinical test offerings in oncology and reproductive genomics. This strategic partnership reflects the leverage of Ultima's advanced sequencing technology to improve diagnostic precision and efficiency. [Published On: October 03, 2024]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Genomics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 23andMe Holding Co., Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Centogene N.V., EPIC Sciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare (Now Cytiva) by Danaher Corporation, Gencove, Inc., GenScript Biotech Corporation, Guardant Health, Inc., Helix OpCo, LLC, Illumina, Inc., Invitae Corporation, Merck & Co., Inc., Myriad Genetics Laboratories, Inc., Natera, Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., Quest Diagnostics, SomaLogic, Inc., Sophia Genetics SA, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Consumables
      • Kits & Assays
      • Reagents
    • Instruments
      • Analyzers
      • Sequencers
    • Service
  • Technology
    • Gene Editing Technique
      • CRISPR/Cas9
      • TALENs
      • Zinc Finger Nucleases
    • Microarray Technology
      • Cellular Microarray
      • DNA Microarray
      • Protein Microarray
    • PCR Technology
      • Digital PCR
      • End-Point PCR
      • Real-Time PCR
    • Sequencing Technology
      • Next-Generation Sequencing
      • Sanger Sequencing
      • Third-Generation Sequencing
  • Type
    • Epigenomics
    • Functional Genomics
    • Pharmacogenomics
    • Structural Genomics
  • Applications
    • Animal Genetics
    • Crop Development
    • Diagnostics
    • Drug Discovery & Development
    • Personalized Medicine
    • Research & Development
  • End Users
    • Agribusiness
      • Livestock Companies
      • Seed Companies
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Genomics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Genomics Market, by Offering
  7. Genomics Market, by Technology
  8. Genomics Market, by Type
  9. Genomics Market, by Applications
  10. Genomics Market, by End Users
  11. Americas Genomics Market
  12. Asia-Pacific Genomics Market
  13. Europe, Middle East & Africa Genomics Market
  14. Competitive Landscape
  15. List of Figures [Total: 27]
  16. List of Tables [Total: 555 ]
  17. List of Companies Mentioned [Total: 27]
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive genomics market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.
Frequently Asked Questions
  1. How big is the Genomics Market?
    Ans. The Global Genomics Market size was estimated at USD 52.22 billion in 2024 and expected to reach USD 57.15 billion in 2025.
  2. What is the Genomics Market growth?
    Ans. The Global Genomics Market to grow USD 91.45 billion by 2030, at a CAGR of 9.78%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.